News - 23 Dec `24🎙 Pharma, Startups and AI. Wrapping 2024 and Looking Into 2025

New

In the 17th episode of Deep Dive in Vitiligo, we close out the year by taking a closer look at the latest developments in vitiligo treatments. From groundbreaking breakthroughs to ongoing challenges and future possibilities, we explore how cutting-edge science, innovative strategies, and unique collaborations are shaping the future of care.

Whether it’s pharmaceutical giants or AI-powered startups, this episode offers a fascinating glimpse into the progress being made—and what lies ahead—for vitiligo treatment. It’s a must-listen for anyone curious about the advancements bringing new hope to patients, advocates, and healthcare professionals alike.

🎧 What’s Inside?

- [0:00] Setting the Stage: A look at the $2 billion vitiligo treatment market projected for 2026 and why it still pales in comparison to conditions like psoriasis.
- [4:12] Incyte and Opzelura: The game-changer as the only FDA-approved drug for vitiligo and its impressive clinical results.
- [10:30] The Competitors: Meet Pfizer (Litfulo), Amgen (AMG 714), and Clinuvel (afamelanotide), each bringing their unique strategies to the table.
- [16:45] The Underdogs: Learn about Temprion Therapeutics’ DNA-based innovations and AI-driven solutions from Skynopathy.
- [22:05] Inclusivity in Research: How Clinuvel is prioritizing treatments for darker skin tones and addressing historical research gaps.
- [28:18] Challenges and Risks: Understanding the trade-offs, from long-term effects to immune suppression concerns.
- [34:55] A Global Effort: How researchers, clinicians, and advocates worldwide are collaborating to find a cure.
- [40:12] The Future of Vitiligo Treatments: Personalized medicine, AI breakthroughs, and hopes for whole-body repigmentation.

Why This Matters

Vitiligo affects millions globally, yet for too long, it has been under-researched and misunderstood. This episode explores how the tide is turning, with dedicated efforts leading to breakthrough treatments and renewed hope.

Key Takeaway: Stay Informed & Stay Hopeful

This isn’t just a story of science; it’s a story of resilience and community. Whether you’re living with vitiligo, supporting a loved one, or simply intrigued by medical innovation, this episode is for you.

đŸŽ™ïž Listen Now

Suggested reading:

 



      FAQOther Questions

      • Pyrostegia venusta as a folk medicine for vitiligo?

        Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...

      • How smoking affects vitiligo?

        Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues....

      • Polypodium leucotomos as an adjunct treatment for vitiligo?

        The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...